3a,4,5,6,7,7a-Hexahydro-4,7-methano-1H-indenyl propionate
Common Name: |
3a,4,5,6,7,7a-Hexahydro-4,7-methano-1H-indenyl propionate |
IUPAC Name: |
3-tricyclo[5.2.1.02,6]dec-4-enyl propanoate |
Molecular Formula: |
C7H10O3 |
SMILES: |
CCC(=O)OC1C=CC2C1C3CCC2C3 |
Inchi: |
1S/C13H18O2/c1-2-12(14)15-11-6-5-10-8-3-4-9(7-8)13(10)11/h5-6,8-11,13H,2-4,7H2,1H3 |
Inchi Key: |
BALAUIYKESNHDW-UHFFFAOYSA-N |
Cas No: |
68912-13-0 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
142.15 |
Mass (g/mol) |
206.131 |
Molar Refractivity |
35.62 |
Net Charge |
|
HBD |
1 |
HBA |
3 |
Rt Bonds |
2 |
Rings |
3 |
TPSA |
46.53 |
Hetero Atoms |
2 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
276.15 |
Vapor Pressure (mmHg@25.00 °C) |
0.005 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.57 |
LogP |
2.54 |
iLOGP |
1.68 |
XLOGP3 |
0.66 |
WLOGP |
0.24 |
MLOGP |
-0.57 |
ESOL Log S |
-1.01 |
ESOL Solubility (mg/ml) |
14 |
ESOL Solubility (mol/l) |
0.099 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.21 |
Ali Solubility (mg/ml) |
8.7 |
Ali Solubility (mol/l) |
0.06 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-0.73 |
Silicos-IT Solubility (mg/ml) |
26.2 |
Silicos-IT Solubility (mol/l) |
0.18 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.70 |
Bioavailability Score |
0.85 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.338 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.338 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |